CUP: D59I23000560006
ACQUISTO VACCINI ANTI SARS-COV2
SUMMARY OF THE PROJECT
ACQUISTO VACCINI ANTI SARS-COV2 PER COMAPGNA VACCINALE
Implementation indicator
Valore dei farmaci, test di screening e trattamenti collegati a COVID-19 acquistati (costo pubblico totale)
- Target
- 33,849,540.74 euro
- Achieved
- 33,849,540.74 euro
Download project
Funding monitored
€ 33,849,540.74
of which cohesion funds
€ 33,849,540.74
| Given name | Amount |
|---|---|
| European Union | 26717442.51 |
| Revolving Fund | 7132098.23 |
Payments monitored
€ 33,849,540.74
of which cohesion funds
€ 33,849,540.74
| Year | Amount | Cumulative amount | Percentage on public financing |
|---|---|---|---|
| 2021 | 12571277.91 | 12571277.91 | 37 |
| 2022 | 21278262.83 | 33849540.74 | 100 |
State of progress
Settled
Expected start: 01/01/2020
Effective start: not available
Expected end: 01/01/2020
Effective end: not available
Entities
Programming area
- Programme
- ROP ERDF ESF CALABRIA
- European Regional Development Fund (ERDF)
- 2014-2020 EU Structural Funds
- Cohesion funds
- € 33,849,540.74
- Payments on cohesion funds
- € 33,849,540.74
- Axis
- Promozione della Ricerca e dell'Innovazione
- Specific objective
- Promozione degli investimenti necessari per il rafforzamento della capacità di risposta alla crisi nei servizi sanitari